The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians
Crossref DOI link: https://doi.org/10.1186/s40248-016-0038-3
Published Online: 2016-01-27
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sommariva, Silvia
Finch, Aureliano P.
Jommi, Claudio
Funding for this research was provided by:
GlaxoSmithKline
Text and Data Mining valid from 2015-12-01
Article History
Received: 3 June 2015
Accepted: 5 January 2016
First Online: 27 January 2016